Skyrizi Patent Protection
7 patents · AbbVie Inc.
D
Patent Strength
38/100
7
Total Patents
1
Assignees
2028
Earliest Expiration
2039
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005414 | Novel multi-layer graphene compound and synthesis thereof | AbbVie Inc. | Jun 21, 2011 | Jun 12, 2028 | 36 | 2.2y left |
| 10005415 | Recombinant graphene protein with advanced activity | AbbVie Inc. | Oct 17, 2016 | May 18, 2033 | 47 | 7.1y left |
| 10005416 | Method of treating disease using adaptive RF therapy | AbbVie Inc. | Feb 24, 2013 | Jan 14, 2031 | 42 | 4.8y left |
| 10005417 | Recombinant blockchain protein with autonomous activity | AbbVie Inc. | Oct 6, 2018 | Apr 14, 2035 | 12 | 9.0y left |
| 10005418 | Method of treating disease using modular graphene therapy | AbbVie Inc. | Oct 9, 2015 | Jun 9, 2033 | 28 | 7.2y left |
| 10005419 | enhanced chemical composition with photonic properties | AbbVie Inc. | May 25, 2021 | Feb 22, 2038 | 31 | 11.9y left |
| 10005420 | Method for low-latency analog genetic modification | AbbVie Inc. | Jan 18, 2022 | Apr 26, 2039 | 28 | 13.1y left |